Allena Pharmaceuticals, Inc. Cost of Revenue

Cost of Revenue of ALNA for past 10 years: annual, quarterly and twelve month trailing (TTM) including Cost of Revenue growth rates and interactive chart. Cost of revenue refers to the direct costs attributable to the production of the goods or supply of services by an entity. It is also commonly known as the “cost of goods sold (COGS)”. Cost of sales measures the cost of goods produced or services provided in a period by an entity. It includes the cost of the direct materials used in producing the goods, direct labor costs used to produce the good, along with any other direct costs associated with the production of goods. In case of services cost of sales includes the labor cost or salaries of the employees and other directly attributable costs. Cost of sales does not include indirect expenses such as distribution costs and marketing costs. It appears on the income statement and is deducted from the sales revenue for the calculation of gross profit (or gross margin).


Highlights and Quick Summary

  • Cost of Revenue for the quarter ending December 31, 2021 was $213 Thousand (a 13.9% increase compared to previous quarter)
  • Year-over-year quarterly Cost of Revenue increased by 43.92%
  • Annual Cost of Revenue for 2021 was $735 Thousand (a -4.17% decrease from previous year)
  • Annual Cost of Revenue for 2020 was $767 Thousand (a 370.55% increase from previous year)
  • Annual Cost of Revenue for 2019 was $163 Thousand (a 108.97% increase from previous year)
  • Twelve month Cost of Revenue ending December 31, 2021 was $735 Thousand (a -3.92% decrease compared to previous quarter)
  • Twelve month trailing Cost of Revenue decreased by -0.68% year-over-year
Trailing Cost of Revenue for the last four month:
31 Dec '21 30 Sep '21 30 Jun '21 31 Mar '21
$735 Thousand $765 Thousand $751 Thousand $740 Thousand
Visit stockrow.com/ALNA for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Cost of Revenue of Allena Pharmaceuticals, Inc.

Most recent Cost of Revenueof ALNA including historical data for past 10 years.

Interactive Chart of Cost of Revenue of Allena Pharmaceuticals, Inc.

Allena Pharmaceuticals, Inc. Cost of Revenue for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2021 $0.21 $0.19 $0.19 $0.15 $0.74
2020 $0.24 $0.17 $0.18 $0.18 $0.77
2019 $0.04 $0.16
2018 $0.08
2017 $0.07
2016 $0.05

Business Profile of Allena Pharmaceuticals, Inc.

Sector: Healthcare
Industry: Biotechnology
Allena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes oral enzyme therapeutics to treat patients with rare and severe metabolic, and kidney disorders in the United States. Its lead product candidate is ALLN-346, a novel and urate degrading enzyme for patients with hyperuricemia and gout in the setting of advanced chronic kidney disease. The company was incorporated in 2011 and is headquartered in Newton, Massachusetts.